Misplaced Pages

Antonio Giordano

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Italian-American oncologist, pathologist, geneticist (1962–)
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article reads like a press release or a news article and may be largely based on routine coverage. Please help improve this article and add independent sources. (October 2019)
This article contains wording that promotes the subject in a subjective manner without imparting real information. Please remove or replace such wording and instead of making proclamations about a subject's importance, use facts and attribution to demonstrate that importance. (October 2019) (Learn how and when to remove this message)
A major contributor to this article appears to have a close connection with its subject. Relevant discussion may be found on the talk page. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. Please discuss further on the talk page. (October 2024) (Learn how and when to remove this message)
(Learn how and when to remove this message)

Antonio Giordano
Born (1962-10-11) October 11, 1962 (age 62)
Naples, Campania, Italy
NationalityItalian and American
Alma materUniversity of Naples Federico II
AwardsKnight and Commander of Order of Merit of the Italian Republic; Cross of Merit Melitense from Sovereign Military Order of Malta
Scientific career
FieldsOncology
Institutions
Websitehttps://www.drantoniogiordano.com/

Antonio Giordano, born on October 11, 1962, in Naples, is an Italian-American oncologist, pathologist, geneticist, researcher, and professor. Giordano serves as the Director of the Sbarro Institute for Cancer Research and Molecular Medicine in Philadelphia and is a professor of Anatomy and Pathological Histology in the Department of Medical Biotechnology at the University of Siena.

Giordano is known for his discoveries in cell cycle regulation and tumor development mechanisms. In particular, he isolated the tumor suppressor gene RB2 / p130 and demonstrated its potential to reduce tumor growth when introduced into animal models via a retrovirus. In addition to his scientific achievements, Giordano also works to communicate science to a general audience, particularly on the health risks of toxic waste in the Campania region.

Biography

Antonio Giordano is the son of Giovan Giacomo Giordano (1925–2010), an oncologist and pathologist of Maria Teresa Sgambati. He graduated with a degree in Medicine at the University of Naples in 1986, and later specialized in Anatomy and Pathological Histology at the University of Trieste.

Giordano then moved to the United States to pursue a PhD, studying under Nobel laureate James Dewey Watson at the Cold Spring Harbor Laboratory. During his time there, Giordano made a pivotal discovery linking cell cycle regulation to cancer development. He demonstrated that for normal cells to become neoplastic, oncogenes must interact directly with cyclins, leading to cell cycle deregulation and the onset of a neoplastic phenotype.

In 1992, he moved to Philadelphia, where he held the position of assistant professor at Temple University and then at Thomas Jefferson University. Since 2004, Giordano has been a professor of Anatomy and Pathological Histology at the University of Siena. He also directs the Sbarro Institute for Cancer Research and Molecular Medicine and of the Center for Biotechnology in the College of Science and Technology at Temple University.

Since June 2006, Giordano has been president of the Scientific Committee of the Human Health Foundation Olus and president of the scientific committee for CROM (Oncological Research Center of Mercogliano-AV). There are also several collaborations with Italian universities, such as the Universities of Rome, Naples, Palermo, Messina, Sassari.

Scientific achievements

In 1993, Giordano identified and cloned a new tumor suppressor gene RB2 / p130 which has a primary function in the cell cycle by controlling correct DNA replication and essentially preventing cancer development. The alterations, at the level of these tumor suppressor genes, that is their non-expression or a malfunction, allowing the neoplastic cells to multiply in an uncontrolled way.

In 2000, Giordano led a pioneering gene therapy in vivo using a mouse model with an induced lung tumor. Using the functionally active RB2 / p130 gene, as a vector, a retrovirus, and tumor growth has been shown to be drastically reduced after a single injection of RB2 / p130.

In 2001, Giordano led another study into tumor pathogenesis. The research, conducted using a mouse model, demonstrated that RB2/p130 also functions as an inhibitor of angiogenesis—the process of new blood vessel formation that supports tumor growth. Additionally, two critical regulators of the human genome, CDK9 and CDK10, was identified. These findings contributed to a deeper understanding of cancer development, offering new perspectives on cancer treatment.

In 2004 Giordano discovered NSPs (Novel Structure Proteins), a new protein structure with a potential role in the dynamics of the nucleus during cell division. One protein in particular (Isoform NSP5a3a) is highly expressed in the cell lines of some tumors and could be a very useful tumor marker.

Health and environment

In recent years, Giordano has dedicated numerous efforts to studying the relationship between cancer and environmental pollution in the Italian region of Campania, linking his career as a researcher to that of a science communicator. He was among the first to report an increased incidence of various types of cancer in populations near illegal toxic waste sites. Not only has he published scientific articles on this subject, but he has also committed himself to making the data known through two books on the subject, respectively "Campania, latera di Velini" and "Munizza di stator" edited by Denaro Libri and Minerva respectively. It also launched a petition to protect the environment, signed by over 500 researchers and people from various professional sectors. He has been the promoter of numerous non-profit initiatives aimed at safeguarding the environment and human health. Recently, as evidence of his commitment in this direction, Giordano was appointed Technical Consultant of the Public Prosecutor's Office of Avellino for the Iso Chimica, case and Scientific Director of the Mediterranea - Food and Wine Academy of Naples. He has carried out some scientific studies highlighting the anticancer properties of tomato. Most recently he was the author and promoter of the Veritas pilot study, aimed at clarifying the link between the onset of diseases and exposure to environmental pollutants.

Publications

Giordano is the author of over 600 scientific publications on peer-reviewed journals and holds numerous international patents relating to the discovery of new genes and new methods for the diagnosis and treatment of cancer.

Selected publications

  • Campania, terra Dei Velini, Giulio Taro (coautore), Napoli, Denaro Libri, 2011, ISBN 978-88-7444-067-2. - Libro Bianco
  • Munizza di Stato. Le Terre Dei Fouche Nell 'Italia Dei Velini, Paolo Chiariello (couture), Bologna, Minerva Edizioni,2015, ISBN 978-88-7381-750-5. - Libro itchiest

Awards and recognition

  • Cavaliere dell'Ordine al Merito Della Repubblica Italian (Italia) 2001

  • Commendatore dell'Ordine al Merito Della Repubblica Italian (Italia) 2010
  • Croce al Merito Meli tense, onorificenza del Soprano Militar Ordines di Malta

References

  1. Mayol, X.; Graña, X.; Baldi, A.; Sang, N.; Hu, Q.; Giordano, A. (September 1993). "Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain". Oncogene. 8 (9): 2561–2566. ISSN 0950-9232. PMID 8361765.
  2. Baldi, A.; Boccia, V.; Claudio, P. P.; De Luca, A.; Giordano, A. (May 14, 1996). "Genomic structure of the human retinoblastoma-related Rb2/p130 gene". Proceedings of the National Academy of Sciences of the United States of America. 93 (10): 4629–4632. Bibcode:1996PNAS...93.4629B. doi:10.1073/pnas.93.10.4629. ISSN 0027-8424. PMC 39329. PMID 8643454.
  3. Claudio, P. P.; Howard, C. M.; Baldi, A.; De Luca, A.; Fu, Y.; Condorelli, G.; Sun, Y.; Colburn, N.; Calabretta, B.; Giordano, A. (November 1, 1994). "p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107". Cancer Research. 54 (21): 5556–5560. ISSN 0008-5472. PMID 7923196.
  4. "SMOM, Riccardo Mastrangeli conferisce onorificenza al prof. Antonio Giordano". Dire.it (in Italian). January 7, 2018. Retrieved July 2, 2021.
  5. "Inquirer.com: Philadelphia local news, sports, jobs, cars, homes". www.inquirer.com. Retrieved July 2, 2021.
  6. "Guest Editors". Oncogene. 25 (38): 5187–5188. August 2006. doi:10.1038/sj.onc.1209720. ISSN 1476-5594.
  7. "Combining Rb2 gene with radiation therapy quickens tumor cell death, Temple researchers find". EurekAlert!. Retrieved July 2, 2021.
  8. "Guest Editors". Oncogene. 25 (38): 5187–5188. August 2006. doi:10.1038/sj.onc.1209720. ISSN 1476-5594.
  9. Miller, Creighton J. (January 1, 2009). "Judicial Staff Directory". Reference Reviews. 23 (1): 23–24. doi:10.1108/09504120910925580. ISSN 0950-4125.
  10. "Novel Structure Proteins discovered by Temple University researchers could play a role in apoptosis". Temple Now | news.temple.edu. July 24, 2008. Retrieved July 2, 2021.
  11. "Libro Campania, terra di veleni - A. Giordano - Denarolibri | LaFeltrinelli". www.lafeltrinelli.it (in Italian). Retrieved July 2, 2021.
  12. "Monnezza di Stato. La Terra dei fuochi nell'Italia dei veleni - Antonio Giordano - Paolo Chiariello - - Libro - Minerva Edizioni (Bologna) - Clessidra | IBS". www.ibs.it. Retrieved July 2, 2021.
  13. "Lo studio. Terra dei fuochi e veleni. Nuove prove di contagio". www.avvenire.it (in Italian). December 17, 2019. Retrieved July 2, 2021.
  14. ""Ultima in Campania per sforamenti, metalli e diossina sopra norma: Avellino e l'Irpinia non possono permettersi una qualità dell'aria così scarsa": il monito dello scienziato Giordano - Orticalab.it". www.orticalab.it (in Italian). Retrieved July 2, 2021.
  15. olgiati (December 16, 2020). "'Dieta del pomodoro' speranza contro il cancro allo stomaco". Adnkronos. Retrieved July 2, 2021.
  16. Redazione. "Terra dei Fuochi. Studio "Veritas" rivela alto tasso di metalli pesanti nel sangue | JPress" (in Italian). Retrieved July 2, 2021.
  17. "ANTONIO GIORDANO". scholar.google.com. Retrieved July 2, 2021.
Categories: